UBS Group Raises Moelis & Company (NYSE:MC) Price Target to $47.00

Moelis & Company (NYSE:MC) had its price objective increased by equities researchers at UBS Group from $45.00 to $47.00 in a note issued to investors on Thursday, Benzinga reports. The firm currently has a “sell” rating on the asset manager’s stock. UBS Group’s target price points to a potential downside of 6.36% from the stock’s previous close.

Several other equities analysts also recently weighed in on the company. Keefe, Bruyette & Woods reaffirmed a “market perform” rating and issued a $54.00 target price (down from $58.00) on shares of Moelis & Company in a research report on Thursday. StockNews.com raised Moelis & Company from a “sell” rating to a “hold” rating in a report on Thursday, February 8th. JPMorgan Chase & Co. upped their price target on Moelis & Company from $46.00 to $57.00 and gave the company a “neutral” rating in a report on Thursday, February 8th. The Goldman Sachs Group raised Moelis & Company from a “sell” rating to a “neutral” rating and upped their price target for the company from $53.00 to $58.00 in a report on Wednesday, March 13th. Finally, JMP Securities reiterated a “market perform” rating on shares of Moelis & Company in a research note on Tuesday, April 9th. Two investment analysts have rated the stock with a sell rating and five have given a hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Hold” and an average price target of $50.80.

Moelis & Company Stock Performance

Moelis & Company stock traded down $3.80 during trading on Thursday, reaching $50.19. The company had a trading volume of 588,414 shares, compared to its average volume of 628,436. The firm’s 50-day simple moving average is $54.31 and its 200 day simple moving average is $51.51. Moelis & Company has a 1-year low of $33.87 and a 1-year high of $58.67. The firm has a market capitalization of $3.57 billion, a PE ratio of -138.42 and a beta of 1.35.

Moelis & Company (NYSE:MC) last announced its earnings results on Wednesday, April 24th. The asset manager reported $0.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.11 by $0.11. Moelis & Company had a negative net margin of 2.89% and a negative return on equity of 3.82%. The company had revenue of $217.49 million for the quarter, compared to analysts’ expectations of $219.30 million. During the same quarter in the previous year, the company posted $0.05 EPS. The firm’s quarterly revenue was up 17.4% on a year-over-year basis. Analysts anticipate that Moelis & Company will post 1.47 EPS for the current year.

Insider Transactions at Moelis & Company

In other Moelis & Company news, General Counsel Osamu R. Watanabe sold 7,685 shares of the stock in a transaction on Wednesday, February 21st. The stock was sold at an average price of $52.60, for a total value of $404,231.00. Following the completion of the transaction, the general counsel now owns 6,000 shares in the company, valued at $315,600. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In other Moelis & Company news, insider Christopher Callesano sold 1,040 shares of the company’s stock in a transaction on Thursday, February 8th. The stock was sold at an average price of $53.59, for a total value of $55,733.60. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, General Counsel Osamu R. Watanabe sold 7,685 shares of the stock in a transaction on Wednesday, February 21st. The shares were sold at an average price of $52.60, for a total value of $404,231.00. Following the sale, the general counsel now directly owns 6,000 shares in the company, valued at approximately $315,600. The disclosure for this sale can be found here. Insiders sold 375,185 shares of company stock worth $20,130,225 over the last 90 days. 6.96% of the stock is currently owned by insiders.

Institutional Trading of Moelis & Company

A number of large investors have recently made changes to their positions in the stock. O ROURKE & COMPANY Inc boosted its stake in shares of Moelis & Company by 4.1% during the fourth quarter. O ROURKE & COMPANY Inc now owns 5,644 shares of the asset manager’s stock valued at $317,000 after acquiring an additional 221 shares during the last quarter. Peak Financial Advisors LLC lifted its position in Moelis & Company by 2.9% during the first quarter. Peak Financial Advisors LLC now owns 8,715 shares of the asset manager’s stock worth $495,000 after buying an additional 245 shares during the period. Capital Investment Advisory Services LLC lifted its position in Moelis & Company by 4.4% during the third quarter. Capital Investment Advisory Services LLC now owns 6,023 shares of the asset manager’s stock worth $272,000 after buying an additional 256 shares during the period. Mutual of America Capital Management LLC raised its holdings in shares of Moelis & Company by 0.4% in the 3rd quarter. Mutual of America Capital Management LLC now owns 76,155 shares of the asset manager’s stock worth $3,437,000 after purchasing an additional 268 shares during the period. Finally, Assetmark Inc. raised its holdings in shares of Moelis & Company by 22.5% during the 4th quarter. Assetmark Inc. now owns 1,505 shares of the asset manager’s stock valued at $84,000 after buying an additional 276 shares during the period. Institutional investors and hedge funds own 91.53% of the company’s stock.

Moelis & Company Company Profile

Moelis & Company operates as an investment banking advisory firm. It offers advisory services in the areas of mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters, as well as strategic, capital structure, and private funds advisory.